Major histocompatibility complex class II molecule in non-small cell lung cancer diagnosis, prognosis and treatment

Lung cancer is one of the commonest cancers in the world. More than 70% of lung cancer patients are diagnosed with non-small cell lung cancer (NSCLC). Major histocompatibility complex class II (MHC class II), an important component in antigen presenting process, usually expresses on professional ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hao, Zhao, Sha, Zhang, Xiaoshen, Jia, Keyi, Deng, Juan, Zhou, Caicun, He, Yayi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6733341/
https://www.ncbi.nlm.nih.gov/pubmed/31564911
http://dx.doi.org/10.2147/OTT.S214231

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6733341/
https://www.ncbi.nlm.nih.gov/pubmed/31564911
http://dx.doi.org/10.2147/OTT.S214231

Ejemplares similares